rs376790729
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001048174.2(MUTYH):c.1351G>T(p.Glu451Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. E451E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001048174.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MUTYH | NM_001128425.2 | c.1435G>T | p.Glu479Ter | stop_gained | 14/16 | ENST00000710952.2 | |
MUTYH | NM_001048174.2 | c.1351G>T | p.Glu451Ter | stop_gained | 14/16 | ENST00000456914.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MUTYH | ENST00000710952.2 | c.1435G>T | p.Glu479Ter | stop_gained | 14/16 | NM_001128425.2 | |||
MUTYH | ENST00000456914.7 | c.1351G>T | p.Glu451Ter | stop_gained | 14/16 | 1 | NM_001048174.2 | A1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000263 AC: 4AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251492Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135920
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727248
GnomAD4 genome ? AF: 0.0000263 AC: 4AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 2 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 28, 2024 | This sequence change creates a premature translational stop signal (p.Glu479*) in the MUTYH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MUTYH are known to be pathogenic (PMID: 18534194, 20663686). This variant is present in population databases (no rsID available, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with adenomatous polyposis (PMID: 17949294). This variant is also known as c.1393G>T, p.Glu465Ter. ClinVar contains an entry for this variant (Variation ID: 238337). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Dec 18, 2023 | The c.1435G>T (p.Glu479*) variant in the MUTYH gene causes a premature termination at codon 479. This change is predicted to result in an absent or disrupted protein product. This truncating variant has been reported in the literature in patient(s) affected with adenomatous polyposis (PMID: 17949294). Loss-of-function variants in MUTYH are known to be pathogenic (PMID: 18534194, 20663686). This variant has been identified in 1/221492 chromosomes in the general population by the Genome Aggregation Database (gnomAD) with no homozygote observed. For these reasons, the c.1435G>T (p.Glu479*) variant in the MUTYH gene has been classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 04, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 23, 2018 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Hereditary cancer-predisposing syndrome Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Feb 01, 2023 | This variant changes 1 nucleotide in exon 14 of the MUTYH gene, creating a premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been reported in individuals affected with colorectal adenomas (PMID: 17949294). This variant has been identified in 1/251492 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of MUTYH function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | curation | Sema4, Sema4 | Jun 27, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2021 | The p.E479* pathogenic mutation (also known as c.1435G>T), located in coding exon 14 of the MUTYH gene, results from a G to T substitution at nucleotide position 1435. This changes the amino acid from a glutamic acid to a stop codon within coding exon 14. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 30, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 12393807, 18534194, 17949294, 19806110, 29625052, 12853198, 16557584, 25820570, 22538434, 18787472, 30787465, 20663686) - |
MUTYH-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 04, 2023 | The MUTYH c.1435G>T variant is predicted to result in premature protein termination (p.Glu479*). This variant is alternatively referred to as c.1396G>T (p.Glu466*) in the literature using an alternate transcript (NM_001293190). This variant has been reported in the homozygous state in individuals with adenomatous polyposis (Jones et al. 2002 PubMed ID: 12393807; Samson et al. 2003. PubMed ID: 12853198; Olschwang et al. 2007. PubMed ID: 17949294, referred to as c.1393G>T, p.Glu465*). In vitro experimental studies indicate that this variant impacts protein function (Ali et al. 2008. PubMed ID: 18534194). It is reported in 1 of ~251,000 alleles in gnomAD (http://gnomad.broadinstitute.org/variant/1-45796895-C-A) and is interpreted as pathogenic and likely pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/238337/). Nonsense variants in MUTYH are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at